Quantcast
 
New book by Larry Connors - Click here to read more


GNTA

Genta Receives Complete Response Letter from FDA to Amended Application of Genasense(R) in Patients with Chronic Lymphocytic Leukemia - 12/02 - 05:15 PM ET

GNTA: To Present At Rodman & Renshaw Investment Conference @ 10:20 ET [delayed] - 11/10 - 08:54 AM ET

Genta Incorporated Announces Third Quarter 2008 Financial Results and Corporate Highlights - 11/06 - 07:15 AM ET

Genta Incorporated to Host Conference Call to Discuss Third Quarter Highlights and Financial Results - 10/30 - 08:05 AM ET

GNTA: Conference call regarding Annual Shareholders Meeting @ 11:00 ET Today [delayed] - 10/06 - 08:28 AM ET

Genta to Stay Trading Below $1 - 09/27 - 07:10 AM ET

Genta's Phase III melanoma study receives positive review from DMB - 09/16 - 08:47 AM ET

GNTA: Independent Monitoring Board Recommends Completion of PH 3 AGENDA Trial - 09/15 - 09:24 AM ET

Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma - 09/15 - 08:05 AM ET

Shareholder Alert: The Rosen Law Firm Announces Investigation of Dilutive Financing of Genta Incorporated - 08/09 - 04:11 AM ET

Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights - 08/07 - 07:00 AM ET

Genta Announces Second Quarter 2008 Financial Results and Conference Call - 07/31 - 08:00 AM ET

Genta Tempered by Trial Costs - 07/31 - 07:10 AM ET

FDA accepts Genta's NDA amendment for leukemia drug - 07/15 - 09:33 AM ET

GNTA: FDA Accepts NDA Amendment for Genasense(R) as "Complete Response" - 07/14 - 09:11 AM ET

FDA Accepts Genta's NDA Amendment as Complete Response for Genasense(R) Treatment of Chronic Lymphocytic Leukemia - 07/14 - 08:05 AM ET

FDA lifts clinical hold on Genta's cancer drug - 06/25 - 11:36 AM ET

Genta Updates Progress of its Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma - 06/24 - 08:00 AM ET

GNTA: FDA Lifts Clinical Hold on Tesetaxel Oral Taxane - 06/23 - 08:55 AM ET

FDA Lifts Clinical Hold on Genta's Tesetaxel, a Leading Oral Taxane - 06/23 - 08:17 AM ET

Page 1 of 5     1  2   3   4   5      Previous  |  Next

<< Back to Stock Index

 

Most Popular News
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.